Latest / Decera Clinical Education Oncology Podcast
Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer
In this episode, Nathan Pennell, MD, PhD; Jamie E. Chaft, MD; and Stephen V. Liu, MD, answer questions asked by an audience of healthcare professionals during a live CCO webinar on biomarker-driven therapies for NSCLC. Topics include:
Choosing between immune checkpoint inhibitor monotherapy and combination therapy with an immune checkpoint inhibitor plus chemotherapy for newly diagnosed NSCLC
Incorporating newly approved immunotherapies into practice
Evolving guidelines and recommendations for biomarker testing
RNA- vs DNA-based next-generation sequencing
Interpretation of NGS results
Use of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.